Harvey White

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Devices

Electrocardiography

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
White Harvey D
Is there an acceptable ceiling for bleeding for an antithrombotic drug dose to be tested in a phase 3 trial?
Nikolsky Eugenia; Stone Gregg W; Kirtane Ajay J; Dangas George D; Lansky Alexandra J; McLaurin Brent; Lincoff A Michael; Feit Frederick; Moses Jeffrey W; Fahy Martin; Manoukian Steven V; White Harvey D; Ohman E Magnus; Bertrand Michel E; Cox David A; Mehran Roxana
Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
Moukarbel George V; Signorovitch James E; Pfeffer Marc A; McMurray John J V; White Harvey D; Maggioni Aldo P; Velazquez Eric J; Califf Robert M; Scheiman James M; Solomon Scott D
Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Harvey White (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: White Harvey D
Is there an acceptable ceiling for bleeding for an antithrombotic drug dose to be tested in a phase 3 trial?
European heart journal 2009;30(21):2556-7.
2009: Nikolsky Eugenia; Stone Gregg W; Kirtane Ajay J; Dangas George D; Lansky Alexandra J; McLaurin Brent; Lincoff A Michael; Feit Frederick; Moses Jeffrey W; Fahy Martin; Manoukian Steven V; White Harvey D; Ohman E Magnus; Bertrand Michel E; Cox David A; Mehran Roxana
Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
Journal of the American College of Cardiology 2009;54(14):1293-302.
2009: Moukarbel George V; Signorovitch James E; Pfeffer Marc A; McMurray John J V; White Harvey D; Maggioni Aldo P; Velazquez Eric J; Califf Robert M; Scheiman James M; Solomon Scott D
Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial.
European heart journal 2009;30(18):2226-32.
2009: Berger Jeffrey S; Elliott Laine; Gallup Dianne; Roe Matthew; Granger Christopher B; Armstrong Paul W; Simes R John; White Harvey D; Van de Werf Frans; Topol Eric J; Hochman Judith S; Newby L Kristin; Harrington Robert A; Califf Robert M; Becker Richard C; Douglas Pamela S
Sex differences in mortality following acute coronary syndromes.
JAMA : the journal of the American Medical Association 2009;302(8):874-82.
2009: Mehran Roxana; Nikolsky Eugenia; Lansky Alexandra J; Kirtane Ajay J; Kim Young-Hak; Feit Frederick; Manoukian Steven; Moses Jeffrey W; Ebrahimi Ramin; Ohman E Magnus; White Harvey D; Pocock Stuart J; Dangas George D; Stone Gregg W
Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) substudy.
JACC. Cardiovascular interventions 2009;2(8):748-57.
2009: Lopes Renato D; Elliott Laine E; White Harvey D; Hochman Judith S; Van de Werf Frans; Ardissino Diego; Nielsen Torsten T; Weaver W Douglas; Widimsky Petr; Armstrong Paul W; Granger Christopher B
Antithrombotic therapy and outcomes of patients with atrial fibrillation following primary percutaneous coronary intervention: results from the APEX-AMI trial.
European heart journal 2009;30(16):2019-28.
2009: Prasad Abhiram; Gersh Bernard J; Bertrand Michel E; Lincoff A Michael; Moses Jeffrey W; Ohman E Magnus; White Harvey D; Pocock Stuart J; McLaurin Brent T; Cox David A; Lansky Alexandra J; Mehran Roxana; Stone Gregg W
Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
Journal of the American College of Cardiology 2009;54(5):477-86.
2009: French John K; Harkness Shannon; Sleeper Lynn; Wong S Chiu; Col Jacques; Dzavik Vladimir; White Harvey D; Hochman Judith S
Cardiogenic shock without flow-limiting angiographic coronary artery disease: (from the Should We Emergently Revascularize Occluded Coronary Arteries for Cardiogenic Shock Trial and Registry).
The American journal of cardiology 2009;104(1):24-8.
2009: White Harvey D
Strategies to minimize bleeding complications of percutaneous coronary intervention.
Current opinion in cardiology 2009;24(4):273-8.
2009: Morrow David A; Wiviott Stephen D; White Harvey D; Nicolau Jose C; Bramucci Ezio; Murphy Sabina A; Bonaca Marc P; Ruff Christian T; Scirica Benjamin M; McCabe Carolyn H; Antman Elliott M; Braunwald Eugene
Effect of the novel thienopyridine prasugrel compared with clopidogrel on spontaneous and procedural myocardial infarction in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition with Prasugrel-Thrombolysis in Myocardial Infarction 38: an application of the classification system from the universal definition of myocardial infarction.
Circulation 2009;119(21):2758-64.
2009: Mehran Roxana; Pocock Stuart J; Stone Gregg W; Clayton Tim C; Dangas George D; Feit Frederick; Manoukian Steven V; Nikolsky Eugenia; Lansky Alexandra J; Kirtane Ajay; White Harvey D; Colombo Antonio; Ware James H; Moses Jeffrey W; Ohman E Magnus
Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial.
European heart journal 2009;30(12):1457-66.
2009: Berry Colin; Pieper Karen S; White Harvey D; Solomon Scott D; Van de Werf Frans; Velazquez Eric J; Maggioni Aldo P; Califf Robert M; Pfeffer Marc A; McMurray John J V
Patients with prior coronary artery bypass grafting have a poor outcome after myocardial infarction: an analysis of the VALsartan in acute myocardial iNfarcTion trial (VALIANT).
European heart journal 2009;30(12):1450-6.
2009: Ewen Edward F; Zhao Liping; Kolm Paul; Jurkovitz Claudine; Fidan Dogan; White Harvey D; Gallo Richard; Weintraub William S
Determining the in-hospital cost of bleeding in patients undergoing percutaneous coronary intervention.
Journal of interventional cardiology 2009;22(3):266-73.
2009: Ebrahimi Ramin; Dyke Cornelius; Mehran Roxana; Manoukian Steven V; Feit Frederick; Cox David A; Gersh Bernard J; Ohman E Magnus; White Harvey D; Moses Jeffrey W; Ware James H; Lincoff A Michael; Stone Gregg W
Outcomes following pre-operative clopidogrel administration in patients with acute coronary syndromes undergoing coronary artery bypass surgery: the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
Journal of the American College of Cardiology 2009;53(21):1965-72.
2009: White Harvey D
Pharmacological and clinical profile of bivalirudin in the treatment of patients with acute coronary syndrome.
Expert opinion on drug metabolism & toxicology 2009;5(5):529-38.
2009: Lansky Alexandra J; Mehran Roxana; Cristea Ecatarina; Parise Helen; Feit Frederick; Ohman E Magnus; White Harvey D; Alexander Karen P; Bertrand Michel E; Desmet Walter; Hamon Martial; Stone Gregg W
Impact of gender and antithrombin strategy on early and late clinical outcomes in patients with non-ST-elevation acute coronary syndromes (from the ACUITY trial).
The American journal of cardiology 2009;103(9):1196-203.
2009: Armstrong Paul W; Fu Yuling; Westerhout Cynthia M; Hudson Michael P; Mahaffey Kenneth W; White Harvey D; Todaro Thomas G; Adams Peter X; Aylward Philip E G; Granger Christopher B
Baseline Q-wave surpasses time from symptom onset as a prognostic marker in ST-segment elevation myocardial infarction patients treated with primary percutaneous coronary intervention.
Journal of the American College of Cardiology 2009;53(17):1503-9.
2009: Wang Tracy Y; Zhang Min; Fu Yuling; Armstrong Paul W; Newby L Kristin; Gibson C Michael; Moliterno David J; Van de Werf Frans; White Harvey D; Harrington Robert A; Roe Matthew T
Incidence, distribution, and prognostic impact of occluded culprit arteries among patients with non-ST-elevation acute coronary syndromes undergoing diagnostic angiography.
American heart journal 2009;157(4):716-23.
2009: Lopes Renato D; Alexander Karen P; Manoukian Steven V; Bertrand Michel E; Feit Frederick; White Harvey D; Pollack Charles V; Hoekstra James; Gersh Bernard J; Stone Gregg W; Ohman E Magnus
Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
Journal of the American College of Cardiology 2009;53(12):1021-30.
2009: Gallo Richard; Steinhubl Steven R; White Harvey D; Montalescot Gilles;
Impact of anticoagulation regimens on sheath management and bleeding in patients undergoing elective percutaneous coronary intervention in the STEEPLE trial.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2009;73(3):319-25.
2009: White Harvey D
HORIZONS trial: a step forward for primary percutaneous coronary intervention.
Expert review of cardiovascular therapy 2009;7(2):125-9.
2009: Aoki Jiro; Lansky Alexandra J; Mehran Roxana; Moses Jeffery; Bertrand Michel E; McLaurin Brent T; Cox David A; Lincoff A Michael; Ohman E Magnus; White Harvey D; Parise Helen; Leon Martin B; Stone Gregg W
Early stent thrombosis in patients with acute coronary syndromes treated with drug-eluting and bare metal stents: the Acute Catheterization and Urgent Intervention Triage Strategy trial.
Circulation 2009;119(5):687-98.
2009: Wong C-K; Gao W; Stewart R A H; French J K; Aylward P E G; White H D
Relationship of QRS duration at baseline and changes over 60 min after fibrinolysis to 30-day mortality with different locations of ST elevation myocardial infarction: results from the Hirulog and Early Reperfusion or Occlusion-2 trial.
Heart (British Cardiac Society) 2009;95(4):276-82.
2009: Menon Venu; Pearte Camille A; Buller Christopher E; Steg Ph Gabriel; Forman Sandra A; White Harvey D; Marino Paolo N; Katritsis Demosthenes G; Caramori Paulo; Lasevitch Ricardo; Loboz-Grudzien Krystyna; Zurakowski Aleksander; Lamas Gervasio A; Hochman Judith S
Lack of benefit from percutaneous intervention of persistently occluded infarct arteries after the acute phase of myocardial infarction is time independent: insights from Occluded Artery Trial.
European heart journal 2009;30(2):183-91.
2009: Wong Cheuk-Kit; White Harvey D
Cardiogenic shock from left ventricular dysfunction complicating an acute ST-elevation myocardial infarction.
The American heart hospital journal 2009;7(1):33-8.
2008: Piccini Jonathan P; Hranitzky Patrick M; Kilaru Rakhi; Rouleau Jean-Lucien; White Harvey D; Aylward Philip E; Van de Werf Frans; Solomon Scott D; Califf Robert M; Velazquez Eric J
Relation of mortality to failure to prescribe beta blockers acutely in patients with sustained ventricular tachycardia and ventricular fibrillation following acute myocardial infarction (from the VALsartan In Acute myocardial iNfarcTion trial [VALIANT] Registry).
The American journal of cardiology 2008;102(11):1427-32.
2008: To Andrew C Y; Looi Khang Li; Damianovich Dragan; Taylor Graeme B; Sidebotham David; White Harvey D
A case of cardiogenic shock caused by capecitabine treatment.
Nature clinical practice. Cardiovascular medicine 2008;5(11):725-9.
2008: Alpert Joseph S; Thygesen Kristian; White Harvey D; Jaffe Allan S
Implications of the universal definition of myocardial infarction.
Nature clinical practice. Cardiovascular medicine 2008;5(11):678-9.
2008: Kruk Mariusz; Kadziela Jacek; Reynolds Harmony R; Forman Sandra A; Sadowski Zygmunt; Barton Bruce A; Mark Daniel B; Maggioni Aldo P; Leor Jonathan; Webb John G; Kapeliovich Michael; Marin-Neto Jose A; White Harvey D; Lamas Gervasio A; Hochman Judith S
Predictors of outcome and the lack of effect of percutaneous coronary intervention across the risk strata in patients with persistent total occlusion after myocardial infarction: Results from the OAT (Occluded Artery Trial) study.
JACC. Cardiovascular interventions 2008;1(5):511-20.
2008: Alpert Joseph S; Thygesen Kristian; Jaffe Allan; White Harvey D
The universal definition of myocardial infarction: a consensus document: ischaemic heart disease.
Heart (British Cardiac Society) 2008;94(10):1335-41.
2008: Thygesen Kristian; Alpert Joseph S; Jaffe Allan S; White Harvey D
Diagnostic application of the universal definition of myocardial infarction in the intensive care unit.
Current opinion in critical care 2008;14(5):543-8.
2008: Buller Christopher E; Fu Yuling; Mahaffey Kenneth W; Todaro Thomas G; Adams Peter; Westerhout Cynthia M; White Harvey D; van 't Hof Arnoud W J; Van de Werf Frans J; Wagner Galen S; Granger Christopher B; Armstrong Paul W
ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
Circulation 2008;118(13):1335-46.
2008: White Harvey D; Ohman E Magnus; Lincoff A Michael; Bertrand Michel E; Colombo Antonio; McLaurin Brent T; Cox David A; Pocock Stuart J; Ware James A; Manoukian Steven V; Lansky Alexandra J; Mehran Roxana; Moses Jeffrey W; Stone Gregg W
Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
Journal of the American College of Cardiology 2008;52(10):807-14.
2008: Chan Mark Y; Mahaffey Kenneth W; Sun Lena J; Pieper Karen S; White Harvey D; Aylward Philip E; Ferguson James J; Califf Robert M; Roe Matthew T
Prevalence, predictors, and impact of conservative medical management for patients with non-ST-segment elevation acute coronary syndromes who have angiographically documented significant coronary disease.
JACC. Cardiovascular interventions 2008;1(4):369-78.
2008: White Harvey D; Chew Derek P
Acute myocardial infarction.
Lancet 2008;372(9638):570-84.
2008: Stewart Ralph A H; Kerr Andrew J; Cowan Brett R; Young Alistair A; Occleshaw Christopher; Richards A Mark; Edwards Colin; Whalley Gillian A; Freidlander Denis; Williams Miles; Doughty Robert N; Zeng Irene; White Harvey D;
A randomized trial of the aldosterone-receptor antagonist eplerenone in asymptomatic moderate-severe aortic stenosis.
American heart journal 2008;156(2):348-55.
2008: Lopes Renato D; Alexander Karen P; Marcucci Gretchen; White Harvey D; Spinler Sarah; Col Jacques; Aylward Philip E; Califf Robert M; Mahaffey Kenneth W
Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial.
European heart journal 2008;29(15):1827-33.
2008: White Harvey D
Systems of care: need for hub-and-spoke systems for both primary and systematic percutaneous coronary intervention after fibrinolysis.
Circulation 2008;118(3):219-22.
2008: White Harvey D
Will new higher-precision troponins lead to clarity or confusion?
Current opinion in cardiology 2008;23(4):292-5.
2008: Lopes R D; Pieper K S; Horton J R; Al-Khatib S M; Newby L K; Mehta R H; Van de Werf F; Armstrong P W; Mahaffey K W; Harrington R A; Ohman E M; White H D; Wallentin L; Granger C B
Short- and long-term outcomes following atrial fibrillation in patients with acute coronary syndromes with or without ST-segment elevation.
Heart (British Cardiac Society) 2008;94(7):867-73.
2008: White Harvey D
Evolution of the definition of myocardial infarction: what are the implications of a new universal definition?
Heart (British Cardiac Society) 2008;94(6):679-84.
2008: White Harvey D; Chew Derek P; Hoekstra James W; Miller Chadwick D; Pollack Charles V; Feit Frederick; Lincoff A Michael; Bertrand Michel; Pocock Stuart; Ware James; Ohman E Magnus; Mehran Roxana; Stone Gregg W
Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non-ST-segment elevation acute coronary syndromes managed with an invasive strategy: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
Journal of the American College of Cardiology 2008;51(18):1734-41.
2008: Chew Derek P; Mahaffey Kenneth W; White Harvey D; Huang Zhen; Hoekstra James W; Ferguson James J; Califf Robert M; Aylward Philip E
Coronary artery bypass surgery in patients with acute coronary syndromes is difficult to predict.
American heart journal 2008;155(5):841-7.
2008: Anderson Rachel E; Pfeffer Marc A; Thune Jens Jakob; McMurray John J V; Califf Robert M; Velazquez Eric; White Harvey D; Rouleau Jean L; Skali Hicham; Maggioni Aldo; Solomon Scott D
High-risk myocardial infarction in the young: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
American heart journal 2008;155(4):706-11.
2008: Mehta Rajendra H; Rao Sunil V; Ohman E Magnus; Bates Eric R; Marcucci Gretchen; Zhang Min; Pieper Karen S; Armstrong Paul W; White Harvey D; Van de Werf Frans; Califf Robert M; Granger Christopher B
Variation in the use of stress testing and outcomes in patients with non-ST-elevation acute coronary syndromes: insights from GUSTO IIb.
European heart journal 2008;29(7):880-7.
2008: West Malcolm J; Nestel Paul J; Kirby Adrienne C; Schnabel Renate; Sullivan David; Simes R John; Pollicino Christine; Lubos Edith; Münzel Thomas F; White Harvey D; Tonkin Andrew M; Bickel Christoph; Tiret Laurence; Blankenberg Stefan;
The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study.
European heart journal 2008;29(7):923-31.
2008: White Harvey D; Dalby Anthony J
Heart disease in Soweto: facing a triple threat.
Lancet 2008;371(9616):876-7.
2008: Mahaffey Kenneth W; Yang Qinghong; Pieper Karen S; Antman Elliott M; White Harvey D; Goodman Shaun G; Cohen Marc; Kleiman Neal S; Langer Anatoly; Aylward Philip E; Col Jacques J; Reist Craig; Ferguson James J; Califf Robert M;
Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trial.
Journal of general internal medicine 2008;23(3):310-6.
2008: Stewart Ralph A; North Fiona M; Sharples Katrina J; Simes R John; Tonkin Andrew M; White Harvey D;
Differences in cardiovascular mortality between Australia and New Zealand according to socioeconomic status: findings from the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study.
The New Zealand medical journal 2008;121(1269):11-23.
2008: Montalescot Gilles; Cohen Marc; Salette Genevieve; Desmet Walter J; Macaya Carlos; Aylward Philip E G; Steg Ph Gabriel; White Harvey D; Gallo Richard; Steinhubl Steven R;
Impact of anticoagulation levels on outcomes in patients undergoing elective percutaneous coronary intervention: insights from the STEEPLE trial.
European heart journal 2008;29(4):462-71.
2008: Thygesen Kristian; Alpert Joseph S; White Harvey D;
[Universal definition of the myocardial infarction.]
Kardiologia polska 2008;66(1):47-62.
2008: Rao Sunil V; Chiswell Karen; Sun Jie-Lena; Granger Christopher B; Newby L Kristin; Van de Werf Frans; White Harvey D; Armstong Paul W; Califf Robert M; Harrington Robert A
International variation in the use of blood transfusion in patients with non-ST-segment elevation acute coronary syndromes.
The American journal of cardiology 2008;101(1):25-29.
2008: Berger Jeffrey S; Stebbins Amanda; Granger Christopher B; Ohman Eric M; Armstrong Paul W; Van de Werf Frans; White Harvey D; Simes R John; Harrington Robert A; Califf Robert M; Peterson Eric D
Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapy.
Circulation 2008;117(2):192-9.
2007: Dumaine Raphaelle; Borentain Maria; Bertel Osmund; Bode Christoph; Gallo Richard; White Harvey D; Collet Jean-Philippe; Steinhubl Steven R; Montalescot Gilles
Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials.
Archives of internal medicine 2007;167(22):2423-30.
2007: Stone Gregg W; Ware James H; Bertrand Michel E; Lincoff A Michael; Moses Jeffrey W; Ohman E Magnus; White Harvey D; Feit Frederick; Colombo Antonio; McLaurin Brent T; Cox David A; Manoukian Steven V; Fahy Martin; Clayton Tim C; Mehran Roxana; Pocock Stuart J;
Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial.
JAMA : the journal of the American Medical Association 2007;298(21):2497-506.
2007: Tricoci Pierluigi; Lokhnygina Yuliya; Berdan Lisa G; Steinhubl Steven R; Gulba Dietrich C; White Harvey D; Kleiman Neal S; Aylward Philip E; Langer Anatoly; Califf Robert M; Ferguson James J; Antman Elliott M; Newby L Kristin; Harrington Robert A; Goodman Shaun G; Mahaffey Kenneth W
Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.
Circulation 2007;116(23):2669-77.
2007: Thygesen Kristian; Alpert Joseph S; White Harvey D;
Universal definition of myocardial infarction.
Journal of the American College of Cardiology 2007;50(22):2173-95.
2007: Mark Daniel B; Van de Werf Frans J; Simes R John; White Harvey D; Wallentin Lars C; Califf Robert M; Armstrong Paul W;
Cardiovascular disease on a global scale: defining the path forward for research and practice.
European heart journal 2007;28(21):2678-84.
2007: Thygesen Kristian; Alpert Joseph S; White Harvey D;
Universal definition of myocardial infarction.
European heart journal 2007;28(20):2525-38.
2007: Wong Cheuk-Kit; White Harvey D
Elderly patients should not be denied fibrinolytic therapy.
Nature clinical practice. Cardiovascular medicine 2007;4(10):520-1.
2007: Gabriel Ruvin S; White Harvey D
ExTRACT-TIMI 25 trial: clarifying the role of enoxaparin in patients with ST-elevation myocardial infarction receiving fibrinolysis.
Expert review of cardiovascular therapy 2007;5(5):851-7.
2007: Wong Cheuk-Kit; Newby L Kristin; Bhapker Manju V; Aylward Phil E; Pfisterer Matthias; Alexander Karen P; Armstrong Paul W; Hochman Judith S; Van de Werf Frans; Califf Robert M; White Harvey D;
Use of evidence-based medicine for acute coronary syndromes in the elderly and very elderly: insights from the Sibrafiban vs aspirin to Yield Maximum Protection from ischemic Heart events postacute cOroNary sYndromes trials.
American heart journal 2007;154(2):313-21.
2007: Edmond J J; French J K; Aylward P E G; Wong C K; Stewart R A H; Williams B F; De Pasquale C G; O'connell R L; Van den Berg K; Van de Werf F J; Simes R J; White H D;
Variations in the use of emergency PCI for the treatment of re-infarction following intravenous fibrinolytic therapy: impact on outcomes in HERO-2.
European heart journal 2007;28(12):1418-24.
2007: Alexander Karen P; Newby L Kristin; Armstrong Paul W; Cannon Christopher P; Gibler W Brian; Rich Michael W; Van de Werf Frans; White Harvey D; Weaver W Douglas; Naylor Mary D; Gore Joel M; Krumholz Harlan M; Ohman E Magnus;
Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Circulation 2007;115(19):2570-89.
2007: Alexander Karen P; Newby L Kristin; Cannon Christopher P; Armstrong Paul W; Gibler W Brian; Rich Michael W; Van de Werf Frans; White Harvey D; Weaver W Douglas; Naylor Mary D; Gore Joel M; Krumholz Harlan M; Ohman E Magnus;
Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
Circulation 2007;115(19):2549-69.
2007: White Harvey D; Braunwald Eugene; Murphy Sabina A; Jacob Ashok J; Gotcheva Nina; Polonetsky Leonid; Antman Elliott M
Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25.
European heart journal 2007;28(9):1066-71.
2007: Manoukian Steven V; Feit Frederick; Mehran Roxana; Voeltz Michele D; Ebrahimi Ramin; Hamon Martial; Dangas George D; Lincoff A Michael; White Harvey D; Moses Jeffrey W; King Spencer B; Ohman E Magnus; Stone Gregg W
Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial.
Journal of the American College of Cardiology 2007;49(12):1362-8.
2007: Stone Gregg W; White Harvey D; Ohman E Magnus; Bertrand Michel E; Lincoff A Michael; McLaurin Brent T; Cox David A; Pocock Stuart J; Ware James H; Feit Frederick; Colombo Antonio; Manoukian Steven V; Lansky Alexandra J; Mehran Roxana; Moses Jeffrey W;
Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial.
Lancet 2007;369(9565):907-19.
2007: Mehta Rajendra H; Califf Robert M; Yang Qinghong; Pieper Karen S; White Harvey D; Ohman E Magnus; Harrington Robert A; Granger Christopher B
Impact of initial heart rate and systolic blood pressure on relation of age and mortality among fibrinolytic-treated patients with acute ST-elevation myocardial infarction presenting with cardiogenic shock.
The American journal of cardiology 2007;99(6):793-6.
2007: Stephenson Kent; Skali Hicham; McMurray John J V; Velazquez Eric J; Aylward Philip G; Kober Lars; Van de Werf Frans; White Harvey D; Pieper Karen S; Califf Robert M; Solomon Scott D; Pfeffer Marc A
Long-term outcomes of left bundle branch block in high-risk survivors of acute myocardial infarction: the VALIANT experience.
Heart rhythm : the official journal of the Heart Rhythm Society 2007;4(3):308-13.
2007: Sampson Uchechukwu K; Pfeffer Marc A; McMurray John J V; Lokhnygina Yuliya; White Harvey D; Solomon Scott D;
Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT Trial.
European heart journal 2007;28(6):685-91.
2007: Stone Gregg W; Bertrand Michel E; Moses Jeffrey W; Ohman E Magnus; Lincoff A Michael; Ware James H; Pocock Stuart J; McLaurin Brent T; Cox David A; Jafar M Zubair; Chandna Harish; Hartmann Franz; Leisch Franz; Strasser Ruth H; Desaga Martin; Stuckey Thomas D; Zelman Richard B; Lieber Ira H; Cohen David J; Mehran Roxana; White Harvey D;
Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial.
JAMA : the journal of the American Medical Association 2007;297(6):591-602.
2007: White Harvey D; Gruber Michael; Feyzi Jan; Kaatz Scott; Tse Hung-Fat; Husted Steen; Albers Gregory W
Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V.
Archives of internal medicine 2007;167(3):239-45.
2007: Mehta Rajendra H; Califf Robert M; Garg Jyotsna; White Harvey D; Van de Werf Frans; Armstrong Paul W; Pieper Karen S; Topol Eric J; Granger Christopher B
The impact of anthropomorphic indices on clinical outcomes in patients with acute ST-elevation myocardial infarction.
European heart journal 2007;28(4):415-24.
2007: Doughty Robert Neil; White Harvey D
Carvedilol: use in chronic heart failure.
Expert review of cardiovascular therapy 2007;5(1):21-31.
2007: Dieker Hendrik-Jan; French John K; Joziasse Irene C; Brouwer Marc A; Elliott John; West Teena M; Webber Bruce J; Verheugt Freek W A; White Harvey D
Antiplatelet therapy and progression of coronary artery disease: a placebo-controlled trial with angiographic and clinical follow-up after myocardial infarction.
American heart journal 2007;153(1):66.e1-8.
2007: Cantor Warren J; Mahaffey Kenneth W; Huang Zhen; Das Pranab; Gulba Dietrich C; Glezer Stanislav; Gallo Richard; Ducas John; Cohen Marc; Antman Elliott M; Langer Anatoly; Kleiman Neal S; White Harvey D; Chisholm Robert J; Harrington Robert A; Ferguson James J; Califf Robert M; Goodman Shaun G
Bleeding complications in patients with acute coronary syndrome undergoing early invasive management can be reduced with radial access, smaller sheath sizes, and timely sheath removal.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2007;69(1):73-83.
2007: Stewart Ralph A; White Harvey D
Reducing the lifetime cardiovascular risk of New Zealanders.
The New Zealand medical journal 2007;120(1261):U2708.
2007: Wong Cheuk-Kit; White Harvey D
Direct antithrombins: mechanisms, trials, and role in contemporary interventional medicine.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2007;7(4):249-57.
2007: Hammett Christopher J K; Prapavessis Harry; Baldi J Chris; Ameratunga Rohan; Schoenbeck Uwe; Varo Nerea; French John K; White Harvey D; Stewart Ralph A H
Variation in blood levels of inflammatory markers related and unrelated to smoking cessation in women.
Preventive cardiology 2007;10(2):68-75.
2006: White Harvey D; Kleiman Neal S; Mahaffey Kenneth W; Lokhnygina Yuliya; Pieper Karen S; Chiswell Karen; Cohen Marc; Harrington Robert A; Chew Derek P; Petersen John L; Berdan Lisa G; Aylward Philip E G; Nessel Christopher C; Ferguson James J; Califf Robert M
Efficacy and safety of enoxaparin compared with unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention in the Superior Yield of the New Strategy of Enoxaparin, Revascularization and Glycoprotein IIb/IIIa Inhibitors (SYNERGY) trial.
American heart journal 2006;152(6):1042-50.
2006: Stone Gregg W; McLaurin Brent T; Cox David A; Bertrand Michel E; Lincoff A Michael; Moses Jeffrey W; White Harvey D; Pocock Stuart J; Ware James H; Feit Frederick; Colombo Antonio; Aylward Philip E; Cequier Angel R; Darius Harald; Desmet Walter; Ebrahimi Ramin; Hamon Martial; Rasmussen Lars H; Rupprecht Hans-Jürgen; Hoekstra James; Mehran Roxana; Ohman E Magnus;
Bivalirudin for patients with acute coronary syndromes.
The New England journal of medicine 2006;355(21):2203-16.
2006: Cohen Marc; Mahaffey Kenneth W; Pieper Karen; Pollack Charles V; Antman Elliott M; Hoekstra James; Goodman Shaun G; Langer Anatoly; Col Jacques J; White Harvey D; Califf Robert M; Ferguson James J;
A subgroup analysis of the impact of prerandomization antithrombin therapy on outcomes in the SYNERGY trial: enoxaparin versus unfractionated heparin in non-ST-segment elevation acute coronary syndromes.
Journal of the American College of Cardiology 2006;48(7):1346-54.
2006: Montalescot Gilles; White Harvey D; Gallo Richard; Cohen Marc; Steg P Gabriel; Aylward Philip E G; Bode Christoph; Chiariello Massimo; King Spencer B; Harrington Robert A; Desmet Walter J; Macaya Carlos; Steinhubl Steven R;
Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention.
The New England journal of medicine 2006;355(10):1006-17.
2006: Reed Shelby D; McMurray John J V; Velazquez Eric J; Schulman Kevin A; Califf Robert M; Kober Lars; Maggioni Aldo P; Van de Werf Frans; White Harvey D; Diaz Rafael; Mareev Viatcheslav; Murin Jan;
Geographic variation in the treatment of acute myocardial infarction in the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial.
American heart journal 2006;152(3):500-8.
2006: Wong Cheuk-Kit; Gao Wanzhen; Stewart Ralph A H; van Pelt Niels; French John K; Aylward Philip E G; White Harvey D;
Risk stratification of patients with acute anterior myocardial infarction and right bundle-branch block: importance of QRS duration and early ST-segment resolution after fibrinolytic therapy.
Circulation 2006;114(8):783-9.
2006: Janardhanan Rajesh; Kenchaiah Satish; Velazquez Eric J; Park Yuhyun; McMurray John J V; Weaver W Douglas; Finn Peter V; White Harvey D; Marin-Neto Jose A; O'Connor Chris; Pfeffer Marc A; Califf Robert M; Solomon Scott D;
Extent of coronary artery disease as a predictor of outcomes in acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both.
American heart journal 2006;152(1):183-9.
2006: Alexander Karen P; Newby Laura Kristin; Bhapkar Manju V; White Harvey D; Hochman Judith S; Pfisterer Matthias E; Moliterno David J; Peterson Eric D; Van de Werf Frans; Armstrong Paul W; Califf Robert M;
International variation in invasive care of the elderly with acute coronary syndromes.
European heart journal 2006;27(13):1558-64.
2006: Wong Cheuk-Kit; Gao Wanzhen; Raffel O Christopher; French John K; Stewart Ralph A; White Harvey D;
Initial Q waves accompanying ST-segment elevation at presentation of acute myocardial infarction and 30-day mortality in patients given streptokinase therapy: an analysis from HERO-2.
Lancet 2006;367(9528):2061-7.
2006: Hochman Judith S; Sleeper Lynn A; Webb John G; Dzavik Vladimir; Buller Christopher E; Aylward Philip; Col Jacques; White Harvey D;
Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction.
JAMA : the journal of the American Medical Association 2006;295(21):2511-5.
2006: Raffel O Christopher; White Harvey D
Drug insight: Statin use in the elderly.
Nature clinical practice. Cardiovascular medicine 2006;3(6):318-28.
2006: Bushnell Cheryl D; Griffin Jeffrey; Newby L Kristin; Goldstein Larry B; Mahaffey Kenneth W; Graffagnino Carmelo A; Harrington Robert A; White Harvey D; Simes R John; Califf Robert M; Topol Eric J; Easton J Donald
Statin use and sex-specific stroke outcomes in patients with vascular disease.
Stroke; a journal of cerebral circulation 2006;37(6):1427-31.
2006: Reynolds Harmony R; Anand Sumeet K; Fox Justin M; Harkness Shannon; Dzavik Vladimir; White Harvey D; Webb John G; Gin Kenneth; Hochman Judith S; Picard Michael H
Restrictive physiology in cardiogenic shock: observations from echocardiography.
American heart journal 2006;151(4):890.e9-15.
2006: Edmond John J; French John K; Stewart Ralph A H; Aylward Philip A; De Pasquale Carmen G; Williams Barbara F; O'Connell Rachel L; Simes R John; White Harvey D;
Frequency of recurrent ST-elevation myocardial infarction after fibrinolytic therapy in a different territory as a manifestation of multiple unstable coronary arterial plaques.
The American journal of cardiology 2006;97(7):947-51.
2006: Antman Elliott M; Morrow David A; McCabe Carolyn H; Murphy Sabina A; Ruda Mikhail; Sadowski Zygmunt; Budaj Andrzej; López-Sendón Jose L; Guneri Sema; Jiang Frank; White Harvey D; Fox Keith A A; Braunwald Eugene;
Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction.
The New England journal of medicine 2006;354(14):1477-88.
2006: Hammett Christopher J K; Prapavessis Harry; Baldi J Chris; Varo Nerea; Schoenbeck Uwe; Ameratunga Rohan; French John K; White Harvey D; Stewart Ralph A H
Effects of exercise training on 5 inflammatory markers associated with cardiovascular risk.
American heart journal 2006;151(2):367.e7-367.e16.
2006: Mehta Rajendra H; Marks David; Califf Robert M; Sohn SeeHyang; Pieper Karen S; Van de Werf Frans; Peterson Eric D; Ohman E Magnus; White Harvey D; Topol Eric J; Granger Christopher B
Differences in the clinical features and outcomes in African Americans and whites with myocardial infarction.
The American journal of medicine 2006;119(1):70.e1-8.
2006: Kauf Teresa L; Velazquez Eric J; Crosslin David R; Weaver W Douglas; Diaz Rafael; Granger Christopher B; McMurray John J V; Rouleau Jean-Lucien; Aylward Philip E; White Harvey D; Califf Robert M; Schulman Kevin A
The cost of acute myocardial infarction in the new millennium: evidence from a multinational registry.
American heart journal 2006;151(1):206-12.
2006: Galla John M; Mahaffey Kenneth W; Sapp Shelly K; Alexander John H; Roe Matthew T; Ohman E Magnus; Granger Christopher B; Armstrong Paul W; Harrington Robert A; White Harvey D; Simoons Maarten L; Newby L Kristin; Califf Robert M; Topol Eric J
Elevated creatine kinase-MB with normal creatine kinase predicts worse outcomes in patients with acute coronary syndromes: results from 4 large clinical trials.
American heart journal 2006;151(1):16-24.
2006: Wong Cheuk-Kit; Stewart Ralph A H; Gao Wanzhen; French John K; Raffel Christopher; White Harvey D
Prognostic differences between different types of bundle branch block during the early phase of acute myocardial infarction: insights from the Hirulog and Early Reperfusion or Occlusion (HERO)-2 trial.
European heart journal 2006;27(1):21-8.
2005: Morrow David A; de Lemos James A; Blazing Michael A; Sabatine Marc S; Murphy Sabina A; Jarolim Petr; White Harvey D; Fox Keith A A; Califf Robert M; Braunwald Eugene;
Prognostic value of serial B-type natriuretic peptide testing during follow-up of patients with unstable coronary artery disease.
JAMA : the journal of the American Medical Association 2005;294(22):2866-71.
2005: White Harvey D
Adherence and outcomes: it's more than taking the pills.
Lancet 2005;366(9502):1989-91.
2005: Mahaffey Kenneth W; Cohen Marc; Garg Jyotsna; Antman Elliott; Kleiman Neal S; Goodman Shaun G; Berdan Lisa G; Reist Craig J; Langer Anatoly; White Harvey D; Aylward Philip E; Col Jacques J; Ferguson James J; Califf Robert M;
High-risk patients with acute coronary syndromes treated with low-molecular-weight or unfractionated heparin: outcomes at 6 months and 1 year in the SYNERGY trial.
JAMA : the journal of the American Medical Association 2005;294(20):2594-600.
2005: White Harvey D; Aylward Philip E G; Huang Zhen; Dalby Anthony J; Weaver W Douglas; Barvik Ståle; Marin-Neto José Antonio; Murin Jan; Nordlander Rolf O; van Gilst Wiek H; Zannad Faiez; McMurray John J V; Califf Robert M; Pfeffer Marc A;
Mortality and morbidity remain high despite captopril and/or Valsartan therapy in elderly patients with left ventricular systolic dysfunction, heart failure, or both after acute myocardial infarction: results from the Valsartan in Acute Myocardial Infarction Trial (VALIANT).
Circulation 2005;112(22):3391-9.
2005: Hochman Judith S; Lamas Gervasio A; Knatterud Genell L; Buller Christopher E; Dzavik Vladimir; Mark Daniel B; Reynolds Harmony R; White Harvey D;
Design and methodology of the Occluded Artery Trial (OAT).
American heart journal 2005;150(4):627-42.
2005: Szummer Karolina E; Solomon Scott D; Velazquez Eric J; Kilaru Rakhi; McMurray John; Rouleau Jean-Lucien; Mahaffey Kenneth W; Maggioni Aldo P; Califf Robert M; Pfeffer Marc A; White Harvey D;
Heart failure on admission and the risk of stroke following acute myocardial infarction: the VALIANT registry.
European heart journal 2005;26(20):2114-9.
2005: White Harvey D; Assmann Susan F; Sanborn Timothy A; Jacobs Alice K; Webb John G; Sleeper Lynn A; Wong Cheuk-Kit; Stewart James T; Aylward Philip E G; Wong Shing-Chiu; Hochman Judith S
Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial.
Circulation 2005;112(13):1992-2001.
2005: Wong Cheuk-Kit; White Harvey D
Should bivalirudin be the anticoagulant of choice for percutaneous coronary intervention?
Nature clinical practice. Cardiovascular medicine 2005;2(8):384-5.
2005: Nallamothu Brahmajee K; Bates Eric R; Hochman Judith S; Granger Christopher B; Guetta Victor; Wilcox Robert G; White Harvey D; Armstrong Paul W; Savonitto Stefano; Jia Gang; Lincoff A Michael; Topol Eric J;
Prognostic implication of activated partial thromboplastin time after reteplase or half-dose reteplase plus abciximab: results from the GUSTO-V trial.
European heart journal 2005;26(15):1506-12.
2005: Brener Sorin J; Lincoff A Michael; Bates Eric R; Jia Gang; Armstrong Paul W; Guetta Victor; Hochman Judith S; Savonitto Stefano; Wilcox Robert G; White Harvey D; Topol Eric J;
The relationship between baseline risk and mortality in ST-elevation acute myocardial infarction treated with pharmacological reperfusion: insights from the Global Utilization of Strategies To open Occluded arteries (GUSTO) V trial.
American heart journal 2005;150(1):89-93.
2005: Sleeper Lynn A; Ramanathan Krishnan; Picard Michael H; Lejemtel Thierry H; White Harvey D; Dzavik Vladimir; Tormey Deborah; Avis Nancy E; Hochman Judith S;
Functional status and quality of life after emergency revascularization for cardiogenic shock complicating acute myocardial infarction.
Journal of the American College of Cardiology 2005;46(2):266-73.
2005: Wong Cheuk-Kit; French John K; Aylward Philip E G; Stewart Ralph A H; Gao Wanzhen; Armstrong Paul W; Van De Werf Frans J J; Simes R John; Raffel O Christopher; Granger Christopher B; Califf Robert M; White Harvey D;
Patients with prolonged ischemic chest pain and presumed-new left bundle branch block have heterogeneous outcomes depending on the presence of ST-segment changes.
Journal of the American College of Cardiology 2005;46(1):29-38.
2005: Chew Derek P; Aylward Phil; White Harvey D
Facilitated percutaneous coronary intervention: is this strategy ready for implementation?
Current cardiology reports 2005;7(4):235-41.
2005: Mahaffey Kenneth W; Roe Matthew T; Kilaru Rakhi; French John K; Alexander John H; Berdan Lisa G; Van De Werf Frans; Simoons Maarten L; Weaver W Douglas; White Harvey D; Lincoff A Michael; Kleiman Neal S; Topol Eric J; Harrington Robert A
Characterization of myocardial infarction as an end point in two large trials of acute coronary syndromes.
The American journal of cardiology 2005;95(12):1404-8.
2005: Nestel Paul J; Baghurst Katrine; Colquhoun David M; Simes R John; Mehalski Kirsty; White Harvey D; Tonkin Andrew M; Kirby Adrienne; Pollicino Christine;
Relation of diet to cardiovascular disease risk factors in subjects with cardiovascular disease in Australia and New Zealand: analysis of the Long-Term Intervention with Pravastatin in Ischaemic Disease trial.
The American journal of clinical nutrition 2005;81(6):1322-9.
2005: Mendes Lisa A; Picard Michael H; Sleeper Lynn A; Thompson Christopher R; Jacobs Alice K; White Harvey D; Hochman Judith S; Davidoff Ravin
Cardiogenic shock: predictors of outcome based on right and left ventricular size and function at presentation.
Coronary artery disease 2005;16(4):209-15.
2005: Mehta Rajendra H; Califf Robert M; Garg Jyotsna; Pieper Karen S; Alexander John H; Moliterno David J; Van de Werf Frans; Ohman E Magnus; White Harvey D; Topol Eric J; Granger Christopher B
Association of height with outcomes in patients with acute myocardial infarction receiving reperfusion therapy.
The American journal of cardiology 2005;95(11):1371-5.
2005: Wong Cheuk-Kit; White Harvey D
Value of community-derived risk models for stratifying patients with non-ST elevation acute coronary syndromes.
European heart journal 2005;26(9):851-2.
2005: Meine Trip J; Al-Khatib Sana M; Alexander John H; Granger Christopher B; White Harvey D; Kilaru Rakhi; Williams Kathryn; Ohman E Magnus; Topol Eric; Califf Robert M
Incidence, predictors, and outcomes of high-degree atrioventricular block complicating acute myocardial infarction treated with thrombolytic therapy.
American heart journal 2005;149(4):670-4.
2005: Stewart Ralph A H; White Harvey D; Kirby Adrienne C; Heritier Stephane R; Simes R John; Nestel Paul J; West Malcolm J; Colquhoun David M; Tonkin Andrew M;
White blood cell count predicts reduction in coronary heart disease mortality with pravastatin.
Circulation 2005;111(14):1756-62.
2005: Antman Elliott M; Morrow David A; McCabe Carolyn H; Jiang Frank; White Harvey D; Fox Keith A A; Sharma Divakar; Chew Paul; Braunwald Eugene;
Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25).
American heart journal 2005;149(2):217-26.
2005: Gersh Bernard J; Stone Gregg W; White Harvey D; Holmes David R
Pharmacological facilitation of primary percutaneous coronary intervention for acute myocardial infarction: is the slope of the curve the shape of the future?
JAMA : the journal of the American Medical Association 2005;293(8):979-86.
2005: Mehta Rajendra H; Granger Christopher B; Alexander Karen P; Bossone Eduardo; White Harvey D; Sketch Michael H
Reperfusion strategies for acute myocardial infarction in the elderly: benefits and risks.
Journal of the American College of Cardiology 2005;45(4):471-8.
2005: Labinaz Marino; Mathias Jasmine; Pieper Karen; Granger Christopher B; Lincoff A Michael; Moliterno David J; Van de Werf Frans; Simes John; White Harvey D; Simoons Maarten L; Califf Robert M; Topol Eric J; Armstrong Paul W; Harrington Robert A
Outcomes of patients with acute coronary syndromes and prior percutaneous coronary intervention: a pooled analysis of three randomized clinical trials.
European heart journal 2005;26(2):128-36.
2004: Hammett Christopher J K; Oxenham Helen C; Baldi J Chris; Doughty Robert N; Ameratunga Rohan; French John K; White Harvey D; Stewart Ralph A H
Effect of six months' exercise training on C-reactive protein levels in healthy elderly subjects.
Journal of the American College of Cardiology 2004;44(12):2411-3.
2004: Armstrong Paul W; Newby L Kristin; Granger Christopher B; Lee Kerry L; Simes R John; Van de Werf Frans; White Harvey D; Califf Robert M;
Lessons learned from a clinical trial.
Circulation 2004;110(23):3610-4.
2004: Wong Selwyn P; French John K; Lydon Anna-Maria; Manda Samuel O M; Gao Wanzhen; Ashton Noel G; White Harvey D
Relation of left ventricular sphericity to 10-year survival after acute myocardial infarction.
The American journal of cardiology 2004;94(10):1270-5.
2004: Heeschen Christopher; Hamm Christian W; Mitrovic Veselin; Lantelme Nicte-Ha; White Harvey D;
N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
Circulation 2004;110(20):3206-12.
2004: White Harvey D; Palmeri Sebastian T; Sleeper Lynn A; French John K; Wong Cheuk-Kit; Lowe April M; Crapo Julia W; Koller Patrick T; Baran Kenneth W; Boland Jean L; Hochman Judith S; Wagner Galen S;
Electrocardiographic findings in cardiogenic shock, risk prediction, and the effects of emergency revascularization: results from the SHOCK trial.
American heart journal 2004;148(5):810-7.
2004: Stone Gregg W; Bertrand Michel; Colombo Antonio; Dangas George; Farkouh Michael E; Feit Frederick; Lansky Alexandra J; Lincoff A Michael; Mehran Roxana; Moses Jeffrey W; Ohman Magnus; White Harvey D
Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial: study design and rationale.
American heart journal 2004;148(5):764-75.
2004: Velazquez Eric J; Francis Gary S; Armstrong Paul W; Aylward Phillip E; Diaz Rafael; O'Connor Christopher M; White Harvey D; Henis Marc; Rittenhouse Lois M; Kilaru Rakhi; van Gilst Wiek; Ertl Georg; Maggioni Aldo P; Spac Jiri; Weaver W Douglas; Rouleau Jean-Lucien; McMurray John J V; Pfeffer Marc A; Califf Robert M;
An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry.
European heart journal 2004;25(21):1911-9.
2004: Wong C-K; Hammett C J K; The R; French J K; Gao W; Webber B J; Elliott J M; Hamer A W; Ormiston J A; Webster M W I; Stewart R A H; Ameratunga R V; White H D
Lack of association between baseline plasma homocysteine concentrations and restenosis rates after a first elective percutaneous coronary intervention without stenting.
Heart (British Cardiac Society) 2004;90(11):1299-302.
2004: Parsons Elizabeth; Newby L Kristin; Bhapkar Manjushri V; Alexander Karen P; White Harvey D; Shah Svati H; Bushnell Cheryl D; Califf Robert M;
Postmenopausal hormone use in women with acute coronary syndromes.
Journal of women's health (2002) 2004;13(8):863-71.
2004: de Lemos James A; Blazing Michael A; Wiviott Stephen D; Brady William E; White Harvey D; Fox Keith A A; Palmisano Joanne; Ramsey Karen E; Bilheimer David W; Lewis Eldrin F; Pfeffer M; Califf Robert M; Braunwald Eugene;
Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial.
European heart journal 2004;25(19):1688-94.
2004: Kassem-Moussa Hassan; Mahaffey Kenneth W; Graffagnino Carmelo; Tasissa Gudaye; Sila Cathy A; Simes R John; White Harvey D; Califf Robert M; Bhapkar Manjshri V; Newby L Kristin;
Incidence and characteristics of stroke during 90-day follow-up in patients stabilized after an acute coronary syndrome.
American heart journal 2004;148(3):439-46.
2004: Anavekar Nagesh S; McMurray John J V; Velazquez Eric J; Solomon Scott D; Kober Lars; Rouleau Jean-Lucien; White Harvey D; Nordlander Rolf; Maggioni Aldo; Dickstein Kenneth; Zelenkofske Steven; Leimberger Jeffrey D; Califf Robert M; Pfeffer Marc A
Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction.
The New England journal of medicine 2004;351(13):1285-95.
2004: de Lemos James A; Blazing Michael A; Wiviott Stephen D; Lewis Eldrin F; Fox Keith A A; White Harvey D; Rouleau Jean-Lucien; Pedersen Terje R; Gardner Laura H; Mukherjee Robin; Ramsey Karen E; Palmisano Joanne; Bilheimer David W; Pfeffer Marc A; Califf Robert M; Braunwald Eugene;
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial.
JAMA : the journal of the American Medical Association 2004;292(11):1307-16.
2004: Blazing Michael A; de Lemos James A; White Harvey D; Fox Keith A A; Verheugt Freek W A; Ardissino Diego; DiBattiste Peter M; Palmisano Joanne; Bilheimer David W; Snapinn Steven M; Ramsey Karen E; Gardner Laura H; Hasselblad Vic; Pfeffer Marc A; Lewis Eldrin F; Braunwald Eugene; Califf Robert M;
Safety and efficacy of enoxaparin vs unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes who receive tirofiban and aspirin: a randomized controlled trial.
JAMA : the journal of the American Medical Association 2004;292(1):55-64.
2004: White Harvey D
Heart, lung and circulation: flagship or millstone?
Heart, lung & circulation 2004;13(1):1-2.
2004: Merry Alan F; Raudkivi Peter J; Middleton Neil G; McDougall John M; Nand Parma; Mills Brigid P; Webber Bruce J; Frampton Chris M; White Harvey D
Bivalirudin versus heparin and protamine in off-pump coronary artery bypass surgery.
The Annals of thoracic surgery 2004;77(3):925-31; discussion 931.
2004: White Harvey D; Willerson James T
We must use the knowledge that we have to treat patients with acute coronary syndromes.
Circulation 2004;109(6):698-700.
2004: Kandzari David E; Granger Christopher B; Simoons Maarten L; White Harvey D; Simes John; Mahaffey Kenneth W; Gore Joel; Weaver W Douglas; Longstreth William T; Stebbins Amanda; Lee Kerry L; Califf Robert M; Topol Eric J;
Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial).
The American journal of cardiology 2004;93(4):458-61.
2004: French John K; White Harvey D
Clinical implications of the new definition of myocardial infarction.
Heart (British Cardiac Society) 2004;90(1):99-106.
2004: French John K; Edmond John J; Gao Wanzhen; White Harvey D; Eikelboom John W
Adjunctive use of direct thrombin inhibitors in patients receiving fibrinolytic therapy for acute myocardial infarction.
American journal of cardiovascular drugs : drugs, devices, and other interventions 2004;4(2):107-15.
2003: Newby L Kristin; Bhapkar Manjushri V; White Harvey D; Moliterno David J; LaPointe Nancy M Allen; Kandzari David E; Verheugt Freek W A; Kramer Judith M; Armstrong Paul W; Califf Robert M;
Aspirin use post-acute coronary syndromes: intolerance, bleeding and discontinuation.
Journal of thrombosis and thrombolysis 2003;16(3):119-28.
2003: McLintock Claire; North Robyn A; White Harvey D
Prosthetic heart valves and pregnancy.
Circulation 2003;108(23):e159-60; author reply e159-60.
2003: White Harvey D; French John K
Use of brain natriuretic peptide levels for risk assessment in non-ST-elevation acute coronary syndromes.
Journal of the American College of Cardiology 2003;42(11):1917-20.
2003: Kramer Judith M; Newby L Kristin; Chang Wei Ching; Simes R John; Van de Werf Frans; Granger Christopher B; Lee Kerry L; White Harvey D; Piegas Leopoldo S; Topol Eric J; Califf Robert M; Armstrong Paul W;
International variation in the use of evidence-based medicines for acute coronary syndromes.
European heart journal 2003;24(23):2133-41.
2003: Stewart Ralph A H; North Fiona M; West Teena M; Sharples Katrina J; Simes R John; Colquhoun David M; White Harvey D; Tonkin Andrew M;
Depression and cardiovascular morbidity and mortality: cause or consequence?
European heart journal 2003;24(22):2027-37.
2003: Gerber Ivor L; Stewart Ralph A H; Hammett Christopher J K; Legget Malcolm E; Oxenham Helen; West Teena M; French John K; White Harvey D
Effect of aortic valve replacement on c-reactive protein in nonrheumatic aortic stenosis.
The American journal of cardiology 2003;92(9):1129-32.
2003: Webb John G; Lowe April M; Sanborn Timothy A; White Harvey D; Sleeper Lynn A; Carere Ronald G; Buller Christopher E; Wong S Chiu; Boland Jean; Dzavik Vlad; Porway Mark; Pate Gordon; Bergman Geoffrey; Hochman Judith S;
Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial.
Journal of the American College of Cardiology 2003;42(8):1380-6.
2003: Cohen Marc; Gensini Gian Franco; Maritz Frans; Gurfinkel Enrique P; Huber Kurt; Timerman Ari; Krzeminska-Pakula Maria; Danchin Nicolas; White Harvey D; Santopinto Jose; Bigonzi Frederique; Hecquet Carole; Vittori Luc;
The safety and efficacy of subcutaneous enoxaparin versus intravenous unfractionated heparin and tirofiban versus placebo in the treatment of acute ST-segment elevation myocardial infarction patients ineligible for reperfusion (TETAMI): a randomized trial.
Journal of the American College of Cardiology 2003;42(8):1348-56.
2003: Savonitto S; Armstrong P W; Lincoff A M; Jia G; Sila C A; Booth J; Terrosu P; Cavallini C; White H D; Ardissino D; Califf R M; Topol E J
Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction. Dichotomous response as a function of age in the GUSTO V trial.
European heart journal 2003;24(20):1807-14.
2003: Wong Cheuk-Kit; White Harvey D; Wilcox Robert G; Criger Douglas A; Califf Robert M; Topol Eric J; Ohman E Magnus
Significance of atrial fibrillation during acute myocardial infarction, and its current management: insights from the GUSTO-3 trial.
Cardiac electrophysiology review 2003;7(3):201-7.
2003: White Harvey D
Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors?
Lancet 2003;362(9386):755-7.
2003: White Harvey D
Candesartan and heart failure: the allure of CHARM.
Lancet 2003;362(9386):754-5.
2003: Gerber Ivor L; Stewart Ralph A H; French John K; Legget Malcolm E; Greaves Sally C; West Teena M; Kerr Andrew J; Richards A Mark; White Harvey D
Associations between plasma natriuretic peptide levels, symptoms, and left ventricular function in patients with chronic aortic regurgitation.
The American journal of cardiology 2003;92(6):755-8.
2003: Kong David F; Hasselblad Vic; Harrington Robert A; White Harvey D; Tcheng James E; Kandzari David E; Topol Eric J; Califf Robert M
Meta-analysis of survival with platelet glycoprotein IIb/IIIa antagonists for percutaneous coronary interventions.
The American journal of cardiology 2003;92(6):651-5.
2003: Velazquez Eric J; Pfeffer Marc A; McMurray John V; Maggioni Aldo P; Rouleau Jean Lucien; Van de Werf Frans; Kober Lars; White Harvey D; Swedberg Karl; Leimberger Jeffrey D; Gallo Paul; Sellers Mary Ann; Edwards Susan; Henis Marc; Califf Robert M;
VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context.
European journal of heart failure : journal of the Working Group on Heart Failure of the European Society of Cardiology 2003;5(4):537-44.
2003: Tolleson Thaddeus R; Newby L Kristin; Harrington Robert A; Bhapkar Manjushri V; Verheugt Freek W A; Berger Peter B; Moliterno David J; White Harvey D; Ohman E Magnus; Van de Werf Frans; Topol Eric J; Califf Robert M;
Frequency of stent thrombosis after acute coronary syndromes (from the SYMPHONY and 2nd SYMPHONY trials).
The American journal of cardiology 2003;92(3):330-3.
2003: Wong Cheuk-Kit; White Harvey D
Myocardial infarction: why can't we get the diagnosis right?
European heart journal 2003;24(13):1177-9.
2003: Hyde T A; French J K; Wong C-K; Edwards C; Whitlock R M L; White H D
Associations between ST depression, four year mortality, and in-hospital revascularisation in unselected patients with non-ST elevation acute coronary syndromes.
Heart (British Cardiac Society) 2003;89(5):490-5.
2003: Gerber Ivor L; Stewart Ralph A H; Legget Malcolm E; West Teena M; French Renelle L; Sutton Timothy M; Yandle Timothy G; French John K; Richards A Mark; White Harvey D
Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis.
Circulation 2003;107(14):1884-90.
2003: Al-Khatib Sana M; Stebbins Amanda L; Califf Robert M; Lee Kerry L; Granger Christopher B; White Harvey D; Armstrong Paul W; Topol Eric J; Ohman E Magnus;
Sustained ventricular arrhythmias and mortality among patients with acute myocardial infarction: results from the GUSTO-III trial.
American heart journal 2003;145(3):515-21.
2003: French John K; Ramanathan Krishnan; Stewart James T; Gao Wanzhen; Théroux Pierre; White Harvey D
A score predicts failure of reperfusion after fibrinolytic therapy for acute myocardial infarction.
American heart journal 2003;145(3):508-14.
2003: Williams Barbara F; French John K; White Harvey D;
Informed consent during the clinical emergency of acute myocardial infarction (HERO-2 consent substudy): a prospective observational study.
Lancet 2003;361(9361):918-22.
2003: Newby L K; Bhapkar M V; White H D; Topol E J; Dougherty F C; Harrington R A; Smith M C; Asarch L F; Califf R M;
Predictors of 90-day outcome in patients stabilized after acute coronary syndromes.
European heart journal 2003;24(2):172-81.
2003: Heeschen Christopher; Hamm Christian W; Laufs Ulrich; Böhm Michael; Snapinn Steven; White Harvey D
Withdrawal of statins in patients with acute coronary syndromes.
Circulation 2003;107(3):e27.
2003: Picard Michael H; Davidoff Ravin; Sleeper Lynn A; Mendes Lisa A; Thompson Christopher R; Dzavik Vladimir; Steingart Richard; Gin Ken; White Harvey D; Hochman Judith S;
Echocardiographic predictors of survival and response to early revascularization in cardiogenic shock.
Circulation 2003;107(2):279-84.
2003: French John K; Van de Water Neil S; Sutton Timothy M; Lund Mayanna; Gao WanZhen; McDowell Joanne; Liu-Stratton Yiwen; Pohorence Jeanette; Szymanski Diane; Goldschmidt-Clermont Pascal; White Harvey D; Browett Peter J; Cooke Glen
Potential thrombophilic mutations/polymorphisms in patients with no flow-limiting stenosis after myocardial infarction.
American heart journal 2003;145(1):118-24.
2003: Wong Cheuk-Kit; French John K; Gao Wanzhen; White Harvey D
Relationship between initial white blood cell counts, stage of acute myocardial infarction evolution at presentation, and incidence of Thrombolysis In Myocardial Infarction-3 flow after streptokinase.
American heart journal 2003;145(1):95-102.
2002: Mukherjee Debabrata; Mahaffey Kenneth W; Moliterno David J; Harrington Robert A; Yadav Jay S; Pieper Karen S; Gallup Dianne; Dyke Christopher; Roe Matthew T; Berdan Lisa; Lauer Michael S; Mänttäri Matti; White Harvey D; Califf Robert M; Topol Eric J
Promise of combined low-molecular-weight heparin and platelet glycoprotein IIb/IIIa inhibition: results from Platelet IIb/IIIa Antagonist for the Reduction of Acute coronary syndrome events in a Global Organization Network B (PARAGON B).
American heart journal 2002;144(6):995-1002.
2002: White Harvey D
Things ain't what they used to be: impact of a new definition of myocardial infarction.
American heart journal 2002;144(6):933-7.
2002: O'Shea J Conor; Wilcox Robert G; Skene Allan M; Stebbins Amanda L; Granger Christopher B; Armstrong Paul W; Bode Christoph; Ardissino Diego; Emanuelsson Hakan; Aylward Philip E; White Harvey D; Sadowski Zygmunt; Topol Eric J; Califf Robert M; Ohman E Magnus
Comparison of outcomes of patients with myocardial infarction when living alone versus those not living alone.
The American journal of cardiology 2002;90(12):1374-7.
2002: West Malcolm J; White Harvey D; Simes R John; Kirby Adrienne; Watson John D; Anderson Neil E; Hankey Graeme J; Wonders Susan; Hunt David; Tonkin Andrew M
Risk factors for non-haemorrhagic stroke in patients with coronary heart disease and the effect of lipid-modifying therapy with pravastatin.
Journal of hypertension 2002;20(12):2513-7.
2002: Edwards Colin; Stewart Ralph A H; Ramanathan Krishnan; West Teena M; French John K; White Harvey D
Increased myocardial ischemia after food is not explained by endothelial dysfunction.
American heart journal 2002;144(5):E8.
2002: Lincoff A Michael; Califf Robert M; Van de Werf Frans; Willerson James T; White Harvey D; Armstrong Paul W; Guetta Victor; Gibler W Brian; Hochman Judith S; Bode Christoph; Vahanian Alec; Steg P Gabriel; Ardissino Diego; Savonitto Stefano; Bar Frits; Sadowski Zygmunt; Betriu Amadeo; Booth Joan E; Wolski Kathy; Waller Michael; Topol Eric J;
Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial.
JAMA : the journal of the American Medical Association 2002;288(17):2130-5.
2002: Glasziou Paul P; Eckermann Simon D; Mulray Sarah E; Simes R John; Martin Andrew J; Kirby Adrienne C; Hall Jane P; Caleo Susan; White Harvey D; Tonkin Andrew M
Cholesterol-lowering therapy with pravastatin in patients with average cholesterol levels and established ischaemic heart disease: is it cost-effective?
The Medical journal of Australia 2002;177(8):428-34.
2002: Wong C-K; White H D; Wilcox R G; Criger D A; Califf R M; Topol E J; Ohman E M;
Management and outcome of patients with atrial fibrillation during acute myocardial infarction: the GUSTO-III experience. Global use of strategies to open occluded coronary arteries.
Heart (British Cardiac Society) 2002;88(4):357-62.
2002: Cohen Marc; Théroux Pierre; Borzak Steven; Frey Martin J; White Harvey D; Van Mieghem W; Senatore Fred; Lis Joy; Mukherjee Robin; Harris Kathy; Bigonzi Frederique;
Randomized double-blind safety study of enoxaparin versus unfractionated heparin in patients with non-ST-segment elevation acute coronary syndromes treated with tirofiban and aspirin: the ACUTE II study. The Antithrombotic Combination Using Tirofiban and Enoxaparin.
American heart journal 2002;144(3):470-7.
2002: Wong C-K; French J K; Krucoff M W; Gao W; Aylward P E; White H D
Slowed ST segment recovery despite early infarct artery patency in patients with Q waves at presentation with a first acute myocardial infarction. Implications of initial Q waves on myocyte reperfusion.
European heart journal 2002;23(18):1449-55.
2002: Roffi M; Chew D P; Mukherjee D; Bhatt D L; White J A; Moliterno D J; Heeschen C; Hamm C W; Robbins M A; Kleiman N S; Théroux P; White H D; Topol E J
Platelet glycoprotein IIb/IIIa inhibition in acute coronary syndromes. Gradient of benefit related to the revascularization strategy.
European heart journal 2002;23(18):1441-8.
2002: Juergens Craig P; White Harvey D; Belardi Jorge A; Macaya Carlos; Soler-Soler Jordi; Meyer Beat J; Levy Richard D; Bunt Ton; Menten Joris; Herrmann Howard C; Adgey A A Jennifer; Tarnesby Georgia
A multicenter study of the tolerability of tirofiban versus placebo in patients undergoing planned intracoronary stent placement.
Clinical therapeutics 2002;24(8):1332-44.
2002: Edmond John J; French John K; Henny Hanneke; Belz Lynne M; West Teena; Stewart Ralph; White Harvey D
Prospective evaluation of a chest pain pathway at Green Lane Hospital.
The New Zealand medical journal 2002;115(1158):U103.
2002: Al-Khatib Sana M; Granger Christopher B; Huang Yao; Lee Kerry L; Califf Robert M; Simoons Maarten L; Armstrong Paul W; Van de Werf Frans; White Harvey D; Simes R John; Moliterno David J; Topol Eric J; Harrington Robert A
Sustained ventricular arrhythmias among patients with acute coronary syndromes with no ST-segment elevation: incidence, predictors, and outcomes.
Circulation 2002;106(3):309-12.
2002: Anderson R David; White Harvey D; Ohman E Magnus; Wagner Galen S; Krucoff Mitchell W; Armstrong Paul W; Weaver W Douglas; Gibler W Brian; Stebbins Amanda L; Califf Robert M; Topol Eric J
Predicting outcome after thrombolysis in acute myocardial infarction according to ST-segment resolution at 90 minutes: a substudy of the GUSTO-III trial. Global Use of Strategies To Open occluded coronary arteries.
American heart journal 2002;144(1):81-8.
2002: Wong Cheuk-Kit; French John K; Gao Wanzhen; White Harvey D
Relation of initial platelet counts to Thrombolysis In Myocardial Infarction-3 flow rates at 90 minutes after commencing fibrinolytic therapy in patients with acute myocardial infarction.
The American journal of cardiology 2002;90(1):54-7.
2002: White Harvey D; Chew Derek P
Bivalirudin: an anticoagulant for acute coronary syndromes and coronary interventions.
Expert opinion on pharmacotherapy 2002;3(6):777-88.
2002: Newby L Kristin; Califf Robert M; White Harvey D; Harrington Robert A; Van de Werf Frans; Granger Christopher B; Simes R John; Hasselblad Vic; Armstrong Paul W
The failure of orally administered glycoprotein IIb/IIIa inhibitors to prevent recurrent cardiac events.
The American journal of medicine 2002;112(8):647-58.
2002: Heeschen Christopher; Hamm Christian W; Laufs Ulrich; Snapinn Steven; Böhm Michael; White Harvey D;
Withdrawal of statins increases event rates in patients with acute coronary syndromes.
Circulation 2002;105(12):1446-52.
2002: Wong C-K; French J K; Andrews J; Frey M J; Adgey A A J; Aylward P E; White H D
Usefulness of the presenting electrocardiogram in predicting myocardial salvage with thrombolytic therapy in patients with a first acute myocardial infarction.
European heart journal 2002;23(5):399-404.
2002: French John K; Andrews Jacqueline; Manda Samuel O M; Stewart Ralph A H; McTigue John J C; White Harvey D
Early ST-segment recovery, infarct artery blood flow, and long-term outcome after acute myocardial infarction.
American heart journal 2002;143(2):265-71.
2002: White Harvey D
Improved efficacy and less bleeding: further evidence of a unique uncoupling of benefit and risk with bivalirudin.
American heart journal 2002;143(2):189-92.
2002: Savonitto Stefano; Granger Christopher B; Ardissino Diego; Gardner Laura; Cavallini Claudio; Galvani Marcello; Ottani Filippo; White Harvey D; Armstrong Paul W; Ohman E Magnus; Pieper Karen S; Califf Robert M; Topol Eric J;
The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromes.
Journal of the American College of Cardiology 2002;39(1):22-9.
2001: Roe M T; Granger C B; Puma J A; Hellkamp A S; Hochman J S; Ohman E M; White H D; Van de Werf F; Armstrong P W; Ellis S G; Califf R M; Topol E J
Comparison of benefits and complications of hirudin versus heparin for patients with acute coronary syndromes undergoing early percutaneous coronary intervention.
The American journal of cardiology 2001;88(12):1403-6, A6.
2001: Roffi M; Chew D P; Mukherjee D; Bhatt D L; White J A; Heeschen C; Hamm C W; Moliterno D J; Califf R M; White H D; Kleiman N S; Théroux P; Topol E J
Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes.
Circulation 2001;104(23):2767-71.
2001: Wong C; French J K; Zambanini A; Andrews J; Aylward P E; Adgey A A; Frey M J; White H D
Relation of pathologic Q waves at presentation and time to streptokinase therapy with early changes in infarct-related artery flow and ventricular wall motion.
The American journal of cardiology 2001;88(5):558-61.
2001: Newby L K; Ohman E M; Christenson R H; Moliterno D J; Harrington R A; White H D; Armstrong P W; Van De Werf F; Pfisterer M; Hasselblad V; Califf R M; Topol E J
Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin t-positive status: the paragon-B troponin T substudy.
Circulation 2001;103(24):2891-6.
2001: Amos D J; French J K; Andrews J; Ashton N G; Williams B F; Whitlock R M; Manda S O; White H D
Corrected TIMI frame counts correlate with stenosis severity and infarct zone wall motion after thrombolytic therapy.
American heart journal 2001;141(4):586-91.
2001: Hochman J S; Sleeper L A; White H D; Dzavik V; Wong S C; Menon V; Webb J G; Steingart R; Picard M H; Menegus M A; Boland J; Sanborn T; Buller C E; Modur S; Forman R; Desvigne-Nickens P; Jacobs A K; Slater J N; LeJemtel T H;
One-year survival following early revascularization for cardiogenic shock.
JAMA : the journal of the American Medical Association 2001;285(2):190-2.
2000: White H D
Thrombolytic therapy in the elderly.
Lancet 2000;356(9247):2028-30.
2000: Wong C K; White H D; Wilcox R G; Criger D A; Califf R M; Topol E J; Ohman E M
New atrial fibrillation after acute myocardial infarction independently predicts death: the GUSTO-III experience.
American heart journal 2000;140(6):878-85.
2000: Topol E J; Ohman E M; Armstrong P W; Wilcox R; Skene A M; Aylward P; Simes J; Dalby A; Betriu A; Bode C; White H D; Hochman J S; Emanuelson H; Vahanian A; Sapp S; Stebbins A; Moliterno D J; Califf R M
Survival outcomes 1 year after reperfusion therapy with either alteplase or reteplase for acute myocardial infarction: results from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) III Trial.
Circulation 2000;102(15):1761-5.
2000: Van de Water N S; French J K; Lund M; Hyde T A; White H D; Browett P J
Prevalence of factor V Leiden and prothrombin variant G20210A in patients age <50 years with no significant stenoses at angiography three to four weeks after myocardial infarction.
Journal of the American College of Cardiology 2000;36(3):717-22.
2000: Hochman J S; Buller C E; Sleeper L A; Boland J; Dzavik V; Sanborn T A; Godfrey E; White H D; Lim J; LeJemtel T
Cardiogenic shock complicating acute myocardial infarction--etiologies, management and outcome: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?
Journal of the American College of Cardiology 2000;36(3 Suppl A):1063-70.
2000: White H D; Simes R J; Anderson N E; Hankey G J; Watson J D; Hunt D; Colquhoun D M; Glasziou P; MacMahon S; Kirby A C; West M J; Tonkin A M
Pravastatin therapy and the risk of stroke.
The New England journal of medicine 2000;343(5):317-26.
2000: Woo K S; Armiger L C; White H D; Norris R M
Can streptokinase produce beneficial effects additional to coronary recanalization? Quantitative microvascular analysis of critically injured reperfused myocardium.
Microvascular research 2000;60(1):8-20.
2000: Straznicky I T; White H D
Thrombolytic therapy for acute myocardial infarction in the elderly.
Coronary artery disease 2000;11(4):299-304.
2000: Lund M; French J K; White H D
Occluded infarct-related arteries and clinical events.
Progress in cardiovascular diseases 2000;42(6):405-18.
2000: French J K; Hyde T A; Straznicky I T; Andrews J; Lund M; Amos D J; Zambanini A; Ellis C J; Webber B J; McLaughlin S C; Whitlock R M; Manda S O; Patel H; White H D
Relationship between corrected TIMI frame counts at three weeks and late survival after myocardial infarction.
Journal of the American College of Cardiology 2000;35(6):1516-24.
2000: Andrews J; Straznicky I T; French J K; Green C L; Maas A C; Lund M; Krucoff M W; White H D
ST-Segment recovery adds to the assessment of TIMI 2 and 3 flow in predicting infarct wall motion after thrombolytic therapy.
Circulation 2000;101(18):2138-43.
2000: Menon V; Slater J N; White H D; Sleeper L A; Cocke T; Hochman J S
Acute myocardial infarction complicated by systemic hypoperfusion without hypotension: report of the SHOCK trial registry.
The American journal of medicine 2000;108(5):374-80.
2000: Andrews J; French J K; Manda S O; White H D
New Q waves on the presenting electrocardiogram independently predict increased cardiac mortality following a first ST-elevation myocardial infarction.
European heart journal 2000;21(8):647-53.
2000: Newby L K; Eisenstein E L; Califf R M; Thompson T D; Nelson C L; Peterson E D; Armstrong P W; Van de Werf F; White H D; Topol E J; Mark D B
Cost effectiveness of early discharge after uncomplicated acute myocardial infarction.
The New England journal of medicine 2000;342(11):749-55.
2000: Lund M; French J K; Johnson R N; Williams B F; White H D
Serum troponins T and I after elective cardioversion.
European heart journal 2000;21(3):245-53.
1999: Ohman E M; Armstrong P W; White H D; Granger C B; Wilcox R G; Weaver W D; Gibler W B; Stebbins A L; Cianciolo C; Califf R M; Topol E J
Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarction. GUSTOIII Investigators. Global Use of Strategies To Open Occluded Coronary Arteries.
The American journal of cardiology 1999;84(11):1281-6.
1999: White H D
Newer antiplatelet agents in acute coronary syndromes.
American heart journal 1999;138(6 Pt 2):S570-6.
1999: Kong D F; Topol E J; Bittl J A; White H D; Théroux P; Hasselblad V; Califf R M
Clinical outcomes of bivalirudin for ischemic heart disease.
Circulation 1999;100(20):2049-53.
1999: French J K; White H D
Antithrombin agents as adjuncts to thrombolytic therapy.
Journal of thrombosis and thrombolysis 1999;8(3):159-66.
1999: French J K; White H D
Direct thrombin inhibitors as adjuncts to thrombolytic therapy.
Current cardiology reports 1999;1(3):184-91.
1999: Mahaffey K W; Granger C B; Sloan M A; Green C L; Gore J M; Weaver W D; White H D; Simoons M L; Barbash G I; Topol E J; Califf R M
Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tPA) for Occluded Coronary Arteries.
American heart journal 1999;138(3 Pt 1):493-9.
1999: White H D
Future of reperfusion therapy for acute myocardial infarction.
Lancet 1999;354(9180):695-7.
1999: Hyde T A; French J K; Wong C K; Straznicky I T; Whitlock R M; White H D
Four-year survival of patients with acute coronary syndromes without ST-segment elevation and prognostic significance of 0.5-mm ST-segment depression.
The American journal of cardiology 1999;84(4):379-85.
1999: Hochman J S; Sleeper L A; Webb J G; Sanborn T A; White H D; Talley J D; Buller C E; Jacobs A K; Slater J N; Col J; McKinlay S M; LeJemtel T H
Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.
The New England journal of medicine 1999;341(9):625-34.
1999: White H D
Optimal treatment of patients with acute coronary syndromes and non-ST-elevation myocardial infarction.
American heart journal 1999;138(2 Pt 2):S105-14.
1999: Hochman J S; Tamis J E; Thompson T D; Weaver W D; White H D; Van de Werf F; Aylward P; Topol E J; Califf R M
Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators.
The New England journal of medicine 1999;341(4):226-32.
1999: French J K; Hyde T A; Patel H; Amos D J; McLaughlin S C; Webber B J; White H D
Survival 12 years after randomization to streptokinase: the influence of thrombolysis in myocardial infarction flow at three to four weeks.
Journal of the American College of Cardiology 1999;34(1):62-9.
1999: Seddon M E; French J K; Amos D J; Ramanathan K; McLaughlin S C; White H D
Waiting times and prioritization for coronary artery bypass surgery in New Zealand.
Heart (British Cardiac Society) 1999;81(6):586-92.
1999: North R A; Sadler L; Stewart A W; McCowan L M; Kerr A R; White H D
Long-term survival and valve-related complications in young women with cardiac valve replacements.
Circulation 1999;99(20):2669-76.
1999: Alexander J H; Granger C B; Sadowski Z; Aylward P E; White H D; Thompson T D; Califf R M; Topol E J
Prophylactic lidocaine use in acute myocardial infarction: incidence and outcomes from two international trials. The GUSTO-I and GUSTO-IIb Investigators.
American heart journal 1999;137(5):799-805.
1999: Hasdai D; Lerman A; Rihal C S; Criger D A; Garratt K N; Betriu A; White H D; Topol E J; Granger C B; Ellis S G; Califf R M; Holmes D R
Smoking status and outcome after primary coronary angioplasty for acute myocardial infarction.
American heart journal 1999;137(4 Pt 1):612-20.
1999: Puma J A; Sketch M H; Thompson T D; Simes R J; Morris D C; White H D; Topol E J; Califf R M
Support for the open-artery hypothesis in survivors of acute myocardial infarction: analysis of 11,228 patients treated with thrombolytic therapy.
The American journal of cardiology 1999;83(4):482-7.
1999: White H D
Is thrombin a pharmacological target during reperfusion?
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 1999;10 Suppl 1():S55-7.
1999: Holmes D R; White H D; Pieper K S; Ellis S G; Califf R M; Topol E J
Effect of age on outcome with primary angioplasty versus thrombolysis.
Journal of the American College of Cardiology 1999;33(2):412-9.
1999: French J K; Straznicky I T; Webber B J; Aylward P E; Frey M J; Adgey A A; Williams B F; McLaughlin S C; White H D
Angiographic frame counts 90 minutes after streptokinase predict left ventricular function at 48 hours following myocardial infarction.
Heart (British Cardiac Society) 1999;81(2):128-33.
1999: Wong C K; French J K; Aylward P E; Frey M J; Adgey A A; White H D
Usefulness of the presenting electrocardiogram in predicting successful reperfusion with streptokinase in acute myocardial infarction.
The American journal of cardiology 1999;83(2):164-8.
1999: French J K; Amos D J; Williams B F; Cross D B; Elliott J M; Hart H H; Williams M G; Norris R M; Ashton N G; Whitlock R M; McLaughlin S C; White H D
Effects of early captopril administration after thrombolysis on regional wall motion in relation to infarct artery blood flow.
Journal of the American College of Cardiology 1999;33(1):139-45.
1998: Ellis C J; Zambanini A; French J K; Denton M; Johnson R; Patel H; White H D
Inadequate control of lipid levels in patients with a previous myocardial infarction.
The New Zealand medical journal 1998;111(1079):464-7.
1998: Kong D F; Califf R M; Miller D P; Moliterno D J; White H D; Harrington R A; Tcheng J E; Lincoff A M; Hasselblad V; Topol E J
Clinical outcomes of therapeutic agents that block the platelet glycoprotein IIb/IIIa integrin in ischemic heart disease.
Circulation 1998;98(25):2829-35.
1998: White H D
Direct thrombin inhibition and thrombolytic therapy: rationale for the Hirulog and Early Reperfusion/Occlusion (HERO-2) trial.
The American journal of cardiology 1998;82(8B):57P-62P.
1998: Sloan M A; Sila C A; Mahaffey K W; Granger C B; Longstreth W T; Koudstaal P; White H D; Gore J M; Simoons M L; Weaver W D; Green C L; Topol E J; Califf R M
Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage.
Circulation 1998;98(14):1376-82.
1998: French J K; Ellis C J; White H D
The corrected TIMI frame count. The new gold standard?
Australian and New Zealand journal of medicine 1998;28(4):569-73.
1998: White H D; French J K; Ellis C J
New antiplatelet agents.
Australian and New Zealand journal of medicine 1998;28(4):558-64.
1998: White H D; Ellis C J; French J K
Low molecular weight heparins in acute ischaemic syndromes.
Australian and New Zealand journal of medicine 1998;28(4):555-7.
1998: White H D; Ellis C J; French J K; Aylward P
Hirudin (desirudin) and Hirulog (bivalirudin) in acute ischaemic syndromes and the rationale for the Hirulog/Early Reperfusion Occlusion (HERO-2) Study.
Australian and New Zealand journal of medicine 1998;28(4):551-4.
1998: Ellis C J; French J K; White H D
Thrombolytic eligibility.
Australian and New Zealand journal of medicine 1998;28(4):518-24.
1998: White H D; Braunwald E
Applying the open artery theory: use of predictive survival markers.
European heart journal 1998;19(8):1132-9.
1998: Ellis C J; French J K; White H D; Ormiston J A; Whitlock R M; Webster M W
Results of percutaneous coronary angioplasty in patients <40 years of age.
The American journal of cardiology 1998;82(2):135-9.
1998: Stewart J T; French J K; Théroux P; Ramanathan K; Solymoss B C; Johnson R; White H D
Early noninvasive identification of failed reperfusion after intravenous thrombolytic therapy in acute myocardial infarction.
Journal of the American College of Cardiology 1998;31(7):1499-505.
1998: Metz B K; White H D; Granger C B; Simes R J; Armstrong P W; Hirsh J; Fuster V; MacAulay C M; Califf R M; Topol E J
Randomized comparison of direct thrombin inhibition versus heparin in conjunction with fibrinolytic therapy for acute myocardial infarction: results from the GUSTO-IIb Trial. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO-IIb) Investigators.
Journal of the American College of Cardiology 1998;31(7):1493-8.
1998: Straznicky I T; Zambanini A; White H D
Ongoing clinical trials of anti-platelet agents in the management of acute ischaemic coronary syndromes.
Expert opinion on investigational drugs 1998;7(5):811-21.
1998: Zambanini A; French J K; Webster M W; White H D
The roles for coronary surgery and angioplasty in the management of patients with stable angina: evidence and decision making.
Journal of evaluation in clinical practice 1998;4(2):93-102.
1998: White H D; Van de Werf F J
Thrombolysis for acute myocardial infarction.
Circulation 1998;97(16):1632-46.
1998: French J K; Ellis C J; Webber B J; Williams B F; Amos D J; Ramanathan K; Whitlock R M; White H D
Abnormal coronary flow in infarct arteries 1 year after myocardial infarction is predicted at 4 weeks by corrected Thrombolysis in Myocardial Infarction (TIMI) frame count and stenosis severity.
The American journal of cardiology 1998;81(6):665-71.
1998: Gebel J M; Sila C A; Sloan M A; Granger C B; Mahaffey K W; Weisenberger J; Green C L; White H D; Gore J M; Weaver W D; Califf R M; Topol E J
Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Stroke; a journal of cerebral circulation 1998;29(3):563-9.
1998: Mahaffey K W; Granger C B; Sloan M A; Thompson T D; Gore J M; Weaver W D; White H D; Simoons M L; Barbash G I; Topol E J; Califf R M
Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I.
Circulation 1998;97(8):757-64.
1998: Brieger D B; Mak K H; White H D; Kleiman N S; Miller D P; Vahanian A; Ross A M; Califf R M; Topol E J
Benefit of early sustained reperfusion in patients with prior myocardial infarction (the GUSTO-I trial). Global Utilization of Streptokinase and TPA for occluded arteries.
The American journal of cardiology 1998;81(3):282-7.
1997: Mahaffey K W; Granger C B; Toth C A; White H D; Stebbins A L; Barbash G I; Vahanian A; Topol E J; Califf R M
Diabetic retinopathy should not be a contraindication to thrombolytic therapy for acute myocardial infarction: review of ocular hemorrhage incidence and location in the GUSTO-I trial. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1997;30(7):1606-10.
1997: White H D; Aylward P E; Frey M J; Adgey A A; Nair R; Hillis W S; Shalev Y; Brown M A; French J K; Collins R; Maraganore J; Adelman B
Randomized, double-blind comparison of hirulog versus heparin in patients receiving streptokinase and aspirin for acute myocardial infarction (HERO). Hirulog Early Reperfusion/Occlusion (HERO) Trial Investigators.
Circulation 1997;96(7):2155-61.
1997: Williams B F; French J K; White H D
Is our method of obtaining consent appropriate for randomised controlled trials in acute myocardial infarction?
The New Zealand medical journal 1997;110(1049):298-9.
1997: White H D
Unmet therapeutic needs in the management of acute ischemia.
The American journal of cardiology 1997;80(4A):2B-10B.
1997: Migrino R Q; Young J B; Ellis S G; White H D; Lundergan C F; Miller D P; Granger C B; Ross A M; Califf R M; Topol E J
End-systolic volume index at 90 to 180 minutes into reperfusion therapy for acute myocardial infarction is a strong predictor of early and late mortality. The Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO)-I Angiographic Investigators.
Circulation 1997;96(1):116-21.
1997: Mak K H; Moliterno D J; Granger C B; Miller D P; White H D; Wilcox R G; Califf R M; Topol E J
Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1997;30(1):171-9.
1997: White H D
Clinical trials of direct thrombin inhibitors in acute ischaemic syndromes.
Thrombosis and haemostasis 1997;78(1):364-6.
1997: Moen E K; Asher C R; Miller D P; Weaver W D; White H D; Califf R M; Topol E J
Long-term follow-up of gender-specific outcomes after thrombolytic therapy for acute myocardial infarction from the GUSTO-I trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Journal of women's health / the official publication of the Society for the Advancement of Women's Health Research 1997;6(3):285-93.
1997: Holmes D R; Califf R M; Van de Werf F; Berger P B; Bates E R; Simoons M L; White H D; Thompson T D; Topol E J
Difference in countries' use of resources and clinical outcome for patients with cardiogenic shock after myocardial infarction: results from the GUSTO trial.
Lancet 1997;349(9045):75-8.
1997: Woodfield S L; Lundergan C F; Reiner J S; Thompson M A; Rohrbeck S C; Deychak Y; Smith J O; Burton J R; McCarthy W F; Califf R M; White H D; Weaver W D; Topol E J; Ross A M
Gender and acute myocardial infarction: is there a different response to thrombolysis?
Journal of the American College of Cardiology 1997;29(1):35-42.
1996: Aylward P E; Wilcox R G; Horgan J H; White H D; Granger C B; Califf R M; Topol E J
Relation of increased arterial blood pressure to mortality and stroke in the context of contemporary thrombolytic therapy for acute myocardial infarction. A randomized trial. GUSTO-I Investigators.
Annals of internal medicine 1996;125(11):891-900.
1996: White H D; Barbash G I; Califf R M; Simes R J; Granger C B; Weaver W D; Kleiman N S; Aylward P E; Gore J M; Vahanian A; Lee K L; Ross A M; Topol E J
Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial.
Circulation 1996;94(8):1826-33.
1996: Califf R M; White H D; Van de Werf F; Sadowski Z; Armstrong P W; Vahanian A; Simoons M L; Simes R J; Lee K L; Topol E J
One-year results from the Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries (GUSTO-I) trial. GUSTO-I Investigators.
Circulation 1996;94(6):1233-8.
1996: French J K; Webster M W; Neutze J M; White H D
Evidence-based assessment of the benefit of revascularisation in coronary disease: beyond the randomised trials.
Australian and New Zealand journal of medicine 1996;26(4):490-4.
1996: Norris R M; White H D; Hart H H; Williams B F
Comparison of aspirin with a thromboxane antagonist for patients with prolonged chest pain and ST segment depression.
The New Zealand medical journal 1996;109(1026):278-80.
1996: French J K; Williams B F; Hart H H; Wyatt S; Poole J E; Ingram C; Ellis C J; Williams M G; White H D
Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction.
BMJ (Clinical research ed.) 1996;312(7047):1637-41.
1996: Norris R M; Johnson R N; White H D; Robinson D R
Non-invasive diagnosis of infarct artery patency after acute myocardial infarction by use of serial plasma troponin T concentrations: importance of measurement of peak levels.
Heart (British Cardiac Society) 1996;75(5):481-5.
1996: Weaver W D; White H D; Wilcox R G; Aylward P E; Morris D; Guerci A; Ohman E M; Barbash G I; Betriu A; Sadowski Z; Topol E J; Califf R M
Comparisons of characteristics and outcomes among women and men with acute myocardial infarction treated with thrombolytic therapy. GUSTO-I investigators.
JAMA : the journal of the American Medical Association 1996;275(10):777-82.
1996: Granger C B; Hirsch J; Califf R M; Col J; White H D; Betriu A; Woodlief L H; Lee K L; Bovill E G; Simes R J; Topol E J
Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial.
Circulation 1996;93(5):870-8.
1996: Patel H; Neutze J M; Kerr B; White H D
Failure of implementation of the National Heart Foundation of New Zealand guidelines for the management of dyslipidaemia.
The New Zealand medical journal 1996;109(1015):24-6.
1995: Karnash S L; Granger C B; White H D; Woodlief L H; Topol E J; Califf R M
Treating menstruating women with thrombolytic therapy: insights from the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (GUSTO-I) trial.
Journal of the American College of Cardiology 1995;26(7):1651-6.
1995: Barbash G I; Reiner J; White H D; Wilcox R G; Armstrong P W; Sadowski Z; Morris D; Aylward P; Woodlief L H; Topol E J
Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanism of the "smoker's paradox" from the GUSTO-I trial, with angiographic insights. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries.
Journal of the American College of Cardiology 1995;26(5):1222-9.
1995: Gore J M; Granger C B; Simoons M L; Sloan M A; Weaver W D; White H D; Barbash G I; Van de Werf F; Aylward P E; Topol E J
Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries.
Circulation 1995;92(10):2811-8.
1995: White H D
Angioplasty versus bypass surgery.
Lancet 1995;346(8984):1174-5.
1995: Neutze J M; White H D
A direct threat to research in public hospitals.
The New Zealand medical journal 1995;108(1005):320-2.
1995: White H D; French J K; Norris R M; Williams B F; Hart H H; Cross D B
Effects of streptokinase in patients presenting within 6 hours of prolonged chest pain with ST segment depression.
British heart journal 1995;73(6):500-5.
1995: Barbash G I; White H D; Modan M; Diaz R; Hampton J R; Heikkila J; Kristinsson A; Moulopoulos S; Paolasso E A; Van der Werf T
Acute myocardial infarction in the young--the role of smoking. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
European heart journal 1995;16(3):313-6.
1995: White H D; Cross D B; Williams B F; Norris R M; Woo K S; Hamer A W; Elliott J M; Ormiston J A
"Rescue" thrombolysis with intracoronary tissue plasminogen activator for failed intravenous thrombolysis with streptokinase for acute myocardial infarction.
The American journal of cardiology 1995;75(2):172-4.
1995: White H D; French J K; Hamer A W; Brown M A; Williams B F; Ormiston J A; Cross D B
Frequent reocclusion of patent infarct-related arteries between 4 weeks and 1 year: effects of antiplatelet therapy.
Journal of the American College of Cardiology 1995;25(1):218-23.
1995: White H D
Effects of thrombolytic therapy on left ventricular function and the importance of long-term patency of the infarct-related artery.
Clinical science (London, England : 1979) 1995;88(1):21-4.
1994: Hamer A W; Takayama M; Abraham K A; Roche A H; Kerr A R; Williams B F; Ramage M C; White H D
End-systolic volume and long-term survival after coronary artery bypass graft surgery in patients with impaired left ventricular function.
Circulation 1994;90(6):2899-904.
1994: Kleiman N S; White H D; Ohman E M; Ross A M; Woodlief L H; Califf R M; Holmes D R; Bates E; Pfisterer M; Vahanian A
Mortality within 24 hours of thrombolysis for myocardial infarction. The importance of early reperfusion. The GUSTO Investigators, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.
Circulation 1994;90(6):2658-65.
1994: Granger C B; White H D; Bates E R; Ohman E M; Califf R M
A pooled analysis of coronary arterial patency and left ventricular function after intravenous thrombolysis for acute myocardial infarction.
The American journal of cardiology 1994;74(12):1220-8.
1994: Barbash G I; White H D; Modan M; Diaz R; Hampton J R; Heikkila J; Kristinsson A; Moulopoulos S; Paolasso E A; Van der Werf T
Outcome of thrombolytic therapy in relation to hospital size and invasive cardiac services. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
Archives of internal medicine 1994;154(19):2237-42.
1994: White H D
Aspirin or warfarin for non-rheumatic atrial fibrillation?
Lancet 1994;343(8899):683-4.
1994: White H D; Cross D B; Elliott J M; Norris R M; Yee T W
Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction.
Circulation 1994;89(1):61-7.
1993: White H D; Barbash G I; Modan M; Simes J; Diaz R; Hampton J R; Heikkilä J; Kristinsson A; Moulopoulos S; Paolasso E A
After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Study.
Circulation 1993;88(5 Pt 1):2097-103.
1993: Norris R M; White H D; Cross D B; Woo K S; Maslowski A H; Caruana M P; Hart H H; Williams B
Aspirin does not improve early arterial patency after streptokinase treatment for acute myocardial infarction.
British heart journal 1993;69(6):492-5.
1993: Norris R M; White H D; Cross D B; Woo K S; Elliott J M; Twigden D; Williams B; Johnson R N
Non-invasive diagnosis of arterial patency after thrombolytic treatment and its relation to prognosis.
British heart journal 1993;69(6):485-91.
1993: Hamer A W; White H D
Women and coronary heart disease.
The New Zealand medical journal 1993;106(955):176-7.
1993: Elliott J M; Cross D B; Cederholm-Williams S A; White H D
Neutralizing antibodies to streptokinase four years after intravenous thrombolytic therapy.
The American journal of cardiology 1993;71(8):640-5.
1993: French J K; Elliott J M; Williams B F; Nixon D J; Denton M A; White H D
Association of angiographically detected coronary artery disease with low levels of high-density lipoprotein cholesterol and systemic hypertension.
The American journal of cardiology 1993;71(7):505-10.
1993: Norris R M; Twigden D G; Williams B F; Johnson R N; White H D
Use of creatine kinase isoforms for diagnosis of infarct artery patency after thrombolytic therapy with streptokinase.
Coronary artery disease 1993;4(2):201-5.
1993: Barbash G I; White H D; Modan M; Diaz R; Hampton J R; Heikkila J; Kristinsson A; Moulopoulos S; Paolasso E A; Van der Werf T
Significance of smoking in patients receiving thrombolytic therapy for acute myocardial infarction. Experience gleaned from the International Tissue Plasminogen Activator/Streptokinase Mortality Trial.
Circulation 1993;87(1):53-8.
1992: Norris R M; White H D; Cross D B; Wild C J; Whitlock R M
Prognosis after recovery from myocardial infarction: the relative importance of cardiac dilatation and coronary stenoses.
European heart journal 1992;13(12):1611-8.
1992: White H D
Heart failure: to digitalise or not? The view against.
Australian and New Zealand journal of medicine 1992;22(5 Suppl):626-30.
1992: White H D
Remodelling of the heart after myocardial infarction.
Australian and New Zealand journal of medicine 1992;22(5 Suppl):601-6.
1992: White H D
Thrombolytic therapy for patients with myocardial infarction presenting after six hours.
Lancet 1992;340(8813):221-2.
1992: Norris R M; Ockelford P A; Cross D B; Rivers J T; Smith J M; Takayama M; White H D
Reduced synthesis of tissue plasminogen activator by vascular endothelium during acute myocardial infarction.
Australian and New Zealand journal of medicine 1992;22(3):261-4.
1992: Elliott J M; Williams B F; White H D
Streptokinase and lifestyle outcome in survivors of myocardial infarction.
The New Zealand medical journal 1992;105(933):163-4.
1991: Elliott J M; White H D
Regression of atherosclerosis: fact or fiction?
The New Zealand medical journal 1991;104(925):510-2.
1991: White H D
Comparative safety of thrombolytic agents.
The American journal of cardiology 1991;68(16):30E-37E.
1991: White H D
Thrombolytic therapy. Introduction.
The American journal of cardiology 1991;68(16):1E-2E.
1991: Cross D B; Ashton N G; Norris R M; White H D
Comparison of the effects of streptokinase and tissue plasminogen activator on regional wall motion after first myocardial infarction: analysis by the centerline method with correction for area at risk.
Journal of the American College of Cardiology 1991;17(5):1039-46.
1990: White H D; Cross D B; Williams B F; Norris R M
Safety and efficacy of repeat thrombolytic treatment after acute myocardial infarction.
British heart journal 1990;64(3):177-81.
1990: Rivers J T; White H D; Cross D B; Williams B F; Norris R M
Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: incidence and effect of smoking.
Journal of the American College of Cardiology 1990;16(2):340-8.
1990: White H D
GISSI-2 and the heparin controversy.
Lancet 1990;336(8710):297-8.
1990: White H D
Relation of thrombolysis during acute myocardial infarction to left ventricular function and mortality.
The American journal of cardiology 1990;66(1):92-5.
1990: White H D; Cross D B; Norris R M
Thrombolytic therapy and recurrent myocardial infarction.
The New Zealand medical journal 1990;103(887):163-4.
1990: French J K; White H D; Greaves S C
Simvastatin therapy for hypercholesterolaemia in patients with coronary heart disease.
The New Zealand medical journal 1990;103(883):41-3.
1989: White H D
Acute myocardial infarction: a true medical emergency.
The New Zealand medical journal 1989;102(869):281-3.
1989: White H D
Comparison of tissue plasminogen activator and streptokinase in the management of acute myocardial infarction.
Chest 1989;95(5 Suppl):265S-269S.
1989: White H D; Rivers J T; Maslowski A H; Ormiston J A; Takayama M; Hart H H; Sharpe D N; Whitlock R M; Norris R M
Effect of intravenous streptokinase as compared with that of tissue plasminogen activator on left ventricular function after first myocardial infarction.
The New England journal of medicine 1989;320(13):817-21.
1988: Takayama M; Norris R M; Brown M A; Armiger L C; Rivers J T; White H D
Postsystolic shortening of acutely ischemic canine myocardium predicts early and late recovery of function after coronary artery reperfusion.
Circulation 1988;78(4):994-1007.
1988: Norris R M; White H D
Therapeutic trials in coronary thrombosis should measure left ventricular function as primary end-point of treatment.
Lancet 1988;1(8577):104-6.
1987: White H D; Norris R M; Brown M A; Takayama M; Maslowski A; Bass N M; Ormiston J A; Whitlock T
Effect of intravenous streptokinase on left ventricular function and early survival after acute myocardial infarction.
The New England journal of medicine 1987;317(14):850-5.
1987: White H D; Norris R M; Brown M A; Brandt P W; Whitlock R M; Wild C J
Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.
Circulation 1987;76(1):44-51.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Harvey White

Research Profile (preview)

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Devices

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Harvey White (preview)

All Publications